Overview

Ascorbic Acid, Corticosteroids, and Thiamine in Sepsis (ACTS) Trial

Status:
Completed
Trial end date:
2020-02-28
Target enrollment:
Participant gender:
Summary
In this study, we aim to determine whether the combination of Ascorbic Acid (Vitamin C), Thiamine (Vitamin B1), and Corticosteroids improves the trajectory of organ failure and reduces mortality in patients with sepsis and septic shock as compared to placebo.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Beth Israel Deaconess Medical Center
Collaborator:
Open Philanthropy Project
Treatments:
Ascorbic Acid
Hydrocortisone
Thiamine
Vitamins